Marshall Islands vs New Zealand: Share of adolescent girls vaccinated against human papillomavirus
Marshall Islands
54.0%
in 2024
New Zealand
54.0%
in 2024
Marshall Islands rank
49th
New Zealand rank
49th
Share of adolescent girls vaccinated against human papillomavirus over time
- Marshall Islands
- New Zealand
How they compare
Marshall Islands currently reports 54.0% against 54.0% in New Zealand, a difference of 0.0%.
Across all 12 years both countries report, New Zealand has been ahead every year.
Marshall Islands ranks 49th and New Zealand ranks 49th of 74 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 21.4% | 54.7% | 33.3% | New Zealand |
| 2020s | 50.6% | 64.2% | 13.6% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Marshall Islands or New Zealand?
- Marshall Islands, at 54.0% against 54.0% in New Zealand as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Marshall Islands and New Zealand?
- 0.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and New Zealand?
- 12 years are reported by both, from 2013 to 2024.
- How do Marshall Islands and New Zealand rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Marshall Islands ranks 49th and New Zealand ranks 49th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.